Synmosa Biopharma Corp(TW:4114)
NT$27.75-0.10 (-0.36%)
TW:4114
Synmosa Biopharma Corp etf exposure
NT$27.75
At close:-0.10 (-0.36%)
ETFs with Synmosa Biopharma Corp (4114) Exposure
The following ETFs maintain exposure to Synmosa Biopharma Corp (TW:4114). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
20 ETFs Hold Synmosa Biopharma Corp (4114)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in 4114 |
|---|---|---|---|---|---|---|
| EWX | SPDR S&P Emerging Markets Small Cap ETF | $613.99M | 0.65% | 0.05% | $321.19K | 0.07% |
| AVEE | Avantis Emerging Markets Small Cap Equity ETF | $135.64M | 0.42% | 0.03% | $40.15K | <0.01% |
| XCNY | SPDR S&P Emerging Markets ex-China ETF | $9.36M | 0.19% | 0.02% | $1,974.1 | <0.01% |
| DEXC | Dimensional Emerging Markets ex China Core Equity ETF | $255.98M | 0.43% | 0.01% | $36.69K | <0.01% |
| DFEV | Dimensional Emerging Markets Value ETF | $2.09B | 0.43% | 0.01% | $227.54K | 0.05% |
| VSS | Vanguard FTSE All-World ex-US Small-Cap ETF | $11.10B | 0.06% | 0.01% | $1.57M | 0.31% |
| VSML | Vanguard FTSE Global Small-Cap UCITS ETF Accun USD | $44.70M | 0.25% | <0.01% | $3,713.54 | <0.01% |
| VSMD | Vanguard Funds plc - Vanguard FTSE Global Small-Cap UCITS ETF | $11.91M | 0.25% | <0.01% | $3,713.54 | <0.01% |
| DFSE | Dimensional Emerging Markets Sustainability Core 1 ETF | $574.88M | 0.41% | <0.01% | $47.19K | 0.01% |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | $8.73B | 0.39% | <0.01% | $514.27K | 0.11% |
| V3MA | Vanguard Funds PLC - Vanguard ESG Emerging Markets All Cap UCITS ETF AccumUSD | $114.90M | 0.33% | <0.01% | $5,798.69 | <0.01% |
| V3ML | Vanguard ESG Emerging Markets All Cap UCITS ETF USD | $23.06M | 0.33% | <0.01% | $5,798.69 | <0.01% |
| DFAE | Dimensional Emerging Core Equity Market ETF | $9.01B | 0.29% | <0.01% | $333.26K | 0.07% |
| VWO | Vanguard FTSE Emerging Markets ETF | $119.84B | 0.06% | <0.01% | $5.86M | 1.15% |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | $11.94B | 0.28% | <0.01% | $315.81K | 0.07% |
| VSGX | Vanguard ESG International Stock ETF | $6.57B | 0.10% | <0.01% | $95.04K | 0.02% |
| VXUS | Vanguard Total International Stock ETF | $162.53B | 0.05% | <0.01% | $5.91M | 1.16% |
| VT | Vanguard Total World Stock ETF | $84.05B | 0.06% | <0.01% | $510.34K | 0.10% |
| V3AL | Vanguard ESG Global All CapUCITS ETF USD | $617.89M | 0.26% | <0.01% | $4,009.69 | <0.01% |
| V3AA | Vanguard ESG Global All CapUCITS ETF AccumUSD | $1.24B | 0.26% | <0.01% | $4,009.69 | <0.01% |
Popular ETF Comparisons
4114 ETF Exposure FAQ
What ETFs hold Synmosa Biopharma Corp stock?
Synmosa Biopharma Corp (TW:4114) is currently held by 20 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to TW:4114 include Vanguard (VSS), Dimensional (DFEM) and State Street (EWX).
Which ETF has the largest exposure to TW:4114?
The ETF with the largest exposure to TW:4114 is Vanguard (VSS), with approximately TWD 1.57M in market value exposure.
How much TW:4114 stock is held by ETFs?
ETFs currently hold approximately TWD 2.77M worth of Synmosa Biopharma Corp (TW:4114) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.
